e-learning
resources
Munich 2006
Tuesday 05.09.2006
Biological features, lung function and treatment of lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The clinical significance of soluble E-cadherin in lung cancer
A. Gogali, C. Charalabopoulos, G. Dalavanga, M. Vassiliou, G. Daskalopoulos, S. Constantopoulos (Ioannina, Greece)
Source:
Annual Congress 2006 - Biological features, lung function and treatment of lung cancer
Session:
Biological features, lung function and treatment of lung cancer
Session type:
Electronic Poster Discussion
Number:
4423
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Gogali, C. Charalabopoulos, G. Dalavanga, M. Vassiliou, G. Daskalopoulos, S. Constantopoulos (Ioannina, Greece). The clinical significance of soluble E-cadherin in lung cancer. Eur Respir J 2006; 28: Suppl. 50, 4423
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Expression and significance of VE-cadherin and E-cadherin in non-small cell lung cancer
Source: Annual Congress 2011 - Progress in pathology of lung cancer
Year: 2011
The clinical significance of CD40 molecule expressed on human lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 394s
Year: 2003
Clinicopathological significance and prognostic importance of circulating plasma DNA expression in advanced non-small cell lung cancer and its efficacy as a diagnostic tool
Source: Annual Congress 2012 - New insights in the pathology of lung cancer
Year: 2012
p53 and mdm2 expression in nonsmall cell lung cancer (NSCLC): the lack of prognostic relevance
Source: Eur Respir J 2001; 18: Suppl. 33, 230s
Year: 2001
Clinical significance of serum cathepsin K level during chemotherapy of lung cancer. Can we use it as a marker of small cell lung cancer?
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008
Clinical significance and functional roles of FoxM1 in non-small cell lung cancer
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012
Clinical significance of serum osteopontin levels in lung cancer
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012
Prognostic significance of p53 and bcl-2 abnormalities in operable non-small cell lung cancer
Source: Eur Respir J 2001; 17: 660-666
Year: 2001
The value of CD44 and MMP-2 expression in non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 77s
Year: 2004
The prognostic value of altered pRb and p53 protein expression in non-small cell lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 363s
Year: 2003
Prognostic value of p21 protein expression in non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 674s
Year: 2004
Expression of vascular endothelial-cadherin and epithelial cadherin in non-small cell lung cancer and their clinical significances
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012
Prognostic and potential therapeutic impact of prostate specific membrane antigen expression in non-small cell lung cancer
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018
The association of p53 and p21 expression with clinicopathological parameters and prognosis in non-small cell lung cancer
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010
Clinical and prognostic significance of autoantibodies against recoverin in non small cell lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 394s
Year: 2003
Importance of clusterin expression at tissue level for the prognosis of non-small cells lung cancer
Source: Annual Congress 2009 - Lung cancer biology
Year: 2009
Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications
Source: Eur Respir J 2009; 33: 127-133
Year: 2009
Prognostic significance and correlation between Akt phosphorylation and loss of PTEN protein expression in non-small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 458s
Year: 2005
Clinical evaluation of the plasma levels of hTERT and EGFR expression as markers for early detection of non-small cell lung cancer
Source: Annual Congress 2009 - Basic science and lung cancer
Year: 2009
CD44v6 expression in tissue of patients with lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 77s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept